1. Home
  2. NVCR vs USA Comparison

NVCR vs USA Comparison

Compare NVCR & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • USA
  • Stock Information
  • Founded
  • NVCR 2000
  • USA 1986
  • Country
  • NVCR Switzerland
  • USA United States
  • Employees
  • NVCR N/A
  • USA N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • USA Finance Companies
  • Sector
  • NVCR Health Care
  • USA Finance
  • Exchange
  • NVCR Nasdaq
  • USA Nasdaq
  • Market Cap
  • NVCR 1.4B
  • USA 1.9B
  • IPO Year
  • NVCR 2015
  • USA N/A
  • Fundamental
  • Price
  • NVCR $12.72
  • USA $6.48
  • Analyst Decision
  • NVCR Buy
  • USA
  • Analyst Count
  • NVCR 7
  • USA 0
  • Target Price
  • NVCR $28.79
  • USA N/A
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • USA 880.5K
  • Earning Date
  • NVCR 10-29-2025
  • USA 01-01-0001
  • Dividend Yield
  • NVCR N/A
  • USA 9.66%
  • EPS Growth
  • NVCR N/A
  • USA N/A
  • EPS
  • NVCR N/A
  • USA N/A
  • Revenue
  • NVCR $630,160,000.00
  • USA N/A
  • Revenue This Year
  • NVCR $6.68
  • USA N/A
  • Revenue Next Year
  • NVCR $7.01
  • USA N/A
  • P/E Ratio
  • NVCR N/A
  • USA N/A
  • Revenue Growth
  • NVCR 14.58
  • USA N/A
  • 52 Week Low
  • NVCR $10.87
  • USA $5.62
  • 52 Week High
  • NVCR $34.13
  • USA $7.09
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 53.05
  • USA 39.59
  • Support Level
  • NVCR $11.98
  • USA $6.50
  • Resistance Level
  • NVCR $12.83
  • USA $6.60
  • Average True Range (ATR)
  • NVCR 0.56
  • USA 0.06
  • MACD
  • NVCR 0.16
  • USA -0.01
  • Stochastic Oscillator
  • NVCR 53.43
  • USA 3.03

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

Share on Social Networks: